跳至主要内容
临床试验/NCT00004987
NCT00004987Unknown1 期

Intraperitoneal Dextrin Sulfate in Patients With Advanced HIV Disease: A Phase I Trial

Steinhart Medical Associates2 个研究点 分布在 1 个国家开始时间: 1999年10月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
发起方
试验地点
2

研究概览

简要总结

The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in AIDS patients who have failed conventional anti-HIV treatment.

详细描述

Patients have intraperitoneal (IP) catheter placement done at study entry. Infusion with the carrier vehicle (icodextrin 4%) begins 2 weeks later, and 2 days after that, treatment with dextrin sulphate (DS) commences. DS is given three times per week. A nurse delivers initial treatments and the patient and caregiver will be trained to give subsequent treatments until DS has been given a total of 8 weeks. Patient evaluations are done regularly during treatment and observation continues for 24 weeks.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients may be eligible for this trial if they:
  • Are HIV-positive.
  • Have been diagnosed with AIDS and are under treatment to prevent opportunistic (AIDS-related) infection.
  • Have had a CD4 cell count greater than 50 microL for at least the past 3 months.
  • Have had a viral load of at least 50,000 copies/ml for at least the past 3 months.
  • Have used up all other treatment options.
  • Are able to understand and give written consent.

排除标准

  • Patients may not be eligible for this trial if they:
  • Have been in any other study in the 6 weeks before beginning this study.
  • Have an active, opportunistic infection or other infection.
  • Have any other long-term medical condition or nervous disorder that might make it difficult for them to finish the study.

研究者

发起方
Steinhart Medical Associates
申办方类型
Other

研究点 (2)

Loading locations...

相似试验